Citations (60)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Bimal R. Shah, Eva Scholtus, Catherine Rolland, Ariane Batscheider, Jason N. Katz & Kent R. Nilsson$suffix/text()$suffix/text(). (2019) A rapid evidence assessment of bleed-related healthcare resource utilization in publications reporting the use of direct oral anticoagulants for non-valvular atrial fibrillation. Current Medical Research and Opinion 35:1, pages 127-139.
Read now
Read now
Franklin Michota. (2013) Transitions of care in anticoagulated patients. Journal of Multidisciplinary Healthcare 6, pages 215-228.
Read now
Read now
Articles from other publishers (58)
Meredith J. O’Neil, BreAnn N. Garr, Jenna M. Faircloth, Julie A. Ciambarella, Adam M. Lubert, Nicole L. Nelson & David S. Cooper. (2023) Utility of a pharmacist-managed Anticoagulation Program in patients with congenital heart disease. Cardiology in the Young, pages 1-6.
Crossref
Crossref
M.E. Bauman, A. Hellinger, C. Vander Pluym, R. Bhat, E. Simpson, M. Mehegan, P. Knox & M.P. Massicotte. (2022) Online KidClot education for patients and families initiating warfarin therapy: The eKITE study. Thrombosis Research 215, pages 14-18.
Crossref
Crossref
Teerapon Dhippayom, Kansak Boonpattharatthiti, Treeluck Thammathuros, Piyameth Dilokthornsakul, Itsarawan Sakunrag & Beth Devine. (2021) Clinical Outcomes of Different Warfarin Self-Care Strategies: A Systematic Review and Network Meta-Analysis. Thrombosis and Haemostasis 122:04, pages 492-505.
Crossref
Crossref
Abbie D. Leino, Jeong M. Park & Amy L. Pasternak. (2021) Impact of CYP3A5 phenotype on tacrolimus time in therapeutic range and clinical outcomes in pediatric renal and heart transplant recipients. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 41:8, pages 649-657.
Crossref
Crossref
Hazem Ahmed, Enas Ahmed Saddouh, Mohamed Elhadi Abugrin, Alya Muftah Mohammed Ali, Elham Omran Elgdhafi, Ala Khaled, Ahmed Tarek & Muhammed Elhadi. (2021) Association between Patients’ Knowledge and Adherence to Anticoagulants, and Its Effect on Coagulation Control. Pharmacology 106:5-6, pages 265-274.
Crossref
Crossref
Murat Sargin, Sevinc Bayer Erdogan, Murat Bastopcu, Gokhan Arslanhan, Muge Mete Tasdemir & Gokcen Orhan. (2019) Cost of Healthcare Associated With Deep Vein Thrombosis in Patients Treated With Warfarin in Turkey: 2010-2013 Database Analysis of a Tertiary Care Center. Value in Health Regional Issues 19, pages 81-86.
Crossref
Crossref
Murat Sargin, Muge Mete Tasdemir, Huseyin Kuplay, Sevinc Bayer Erdogan, Nehir Tandogar, Serdar Akansel, Erol Kurc, Gokcen Orhan & Serap Aykut Aka. (2018) Retrospective cohort study for evaluating the INR monitoring patterns in patients with deep vein thrombosis in daily practice: Analysis of 2010–2013 database of a tertiary care center. Phlebology: The Journal of Venous Disease 34:5, pages 317-323.
Crossref
Crossref
Ka-Po Fung, Kei-Hong Chan, Vivien Ng, Ping-Tim Tsui & Joyce H. S. You. (2019) Health Economic Analysis of Rivaroxaban and Warfarin for Venous Thromboembolism Management in Chinese Patients. Cardiovascular Drugs and Therapy 33:3, pages 331-337.
Crossref
Crossref
Revista Fucsalud. (2019) Experiencia de validación de material educativo pacientes anticoagulados en un servicio de consulta externa.. Revista Repertorio de Medicina y Cirugía 28:2.
Crossref
Crossref
Devendra Saksena, Yugal K. Mishra, S. Muralidharan, Vivek Kanhere, Pankaj Srivastava & C. P. Srivastava. (2019) Follow-up and management of valvular heart disease patients with prosthetic valve: a clinical practice guideline for Indian scenario. Indian Journal of Thoracic and Cardiovascular Surgery 35:S1, pages 3-44.
Crossref
Crossref
Vittorio Pengo & Gentian Denas. (2018) Optimizing quality care for the oral vitamin K antagonists (VKAs). Hematology 2018:1, pages 332-338.
Crossref
Crossref
. (2018) Valvular Heart Disease And “Nonvalvular Atrial Fibrillation” Coumadin or a Novel
Oral Anticoagulant Variables to Consider. Cardiology: Open Access 3:1.
Crossref
Crossref
Naoyoshi Nagata, Hideo Yasunaga, Hiroki Matsui, Kiyohide Fushimi, Kazuhiro Watanabe, Junichi Akiyama, Naomi Uemura & Ryota Niikura. (2018) Therapeutic endoscopy-related GI bleeding and thromboembolic events in patients using warfarin or direct oral anticoagulants: results from a large nationwide database analysis. Gut 67:10, pages 1805-1812.
Crossref
Crossref
Tetz C. Lee, Min Qian, Gregory Y.H. Lip, Marco R. Di Tullio, Susan Graham, Douglas L. Mann, Koki Nakanishi, John R. Teerlink, Ronald S. Freudenberger, Ralph L. Sacco, J.P. Mohr, Arthur J. Labovitz, Piotr Ponikowski, Dirk J. Lok, Conrado Estol, Stefan D. Anker, Patrick M. Pullicino, Richard Buchsbaum, Bruce Levin, John L.P. Thompson, Shunichi Homma & Siqin Ye. (2018) Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial). The American Journal of Cardiology 122:5, pages 821-827.
Crossref
Crossref
Natthaporn Sudas Na Ayutthaya, Itsarawan Sakunrak & Teerapon Dhippayom. (2018) Clinical Outcomes of Telemonitoring for Patients on Warfarin after Discharge from Hospital. International Journal of Telemedicine and Applications 2018, pages 1-6.
Crossref
Crossref
Ahmet Guner, Macit Kalcik, Mustafa Ozan Gursoy, Sabahattin Gunduz & Mehmet Ozkan. (2018) What is the importance of real-time three dimensional transesophageal echocardiography and time in therapeutic range in patients with prosthetic valve thrombosis?. Journal of Thrombosis and Thrombolysis 46:1, pages 79-80.
Crossref
Crossref
Subramaniam Thanimalai, Asrul Akmal Shafie, Mohamed Azmi Ahmad Hassali & Jeyaindran Sinnadurai. (2018) Cost-Effectiveness of Warfarin Medication Therapy Adherence Clinic versus Usual Medical Clinic at Kuala Lumpur Hospital. Value in Health Regional Issues 15, pages 34-41.
Crossref
Crossref
Naohiro Yanagisawa, Naoyoshi Nagata, Kazuhiro Watanabe, Tatsuhiro Iida, Mariko Hamada, Sakurako Kobayashi, Takuro Shimbo, Junichi Akiyama & Naomi Uemura. (2018)
Post-polypectomy bleeding and thromboembolism risks associated with warfarin
vs
direct oral anticoagulants
. World Journal of Gastroenterology 24:14, pages 1540-1549.
Crossref
Crossref
Scott Davis, Jane Gralla, Patrick Klem, Suhong Tong, Gina Wedermyer, Brian Freed, Alexander Wiseman & James E. Cooper. (2018) Lower tacrolimus exposure and time in therapeutic range increase the risk of de novo donor-specific antibodies in the first year of kidney transplantation. American Journal of Transplantation 18:4, pages 907-915.
Crossref
Crossref
Kahraman Cosansu, Mehmet Bulent Vatan, Huseyin Gunduz & Ramazan Akdemir. (2018) Use of neutrophil-lymphocyte ratio for risk stratification and relationship with time in therapeutic range in patients with nonvalvular atrial fibrillation: A pilot study. Clinical Cardiology 41:3, pages 339-342.
Crossref
Crossref
Teferi Gedif Fenta, Tamrat Assefa & Bekele Alemayehu. (2017) Quality of anticoagulation management with warfarin among outpatients in a tertiary hospital in Addis Ababa, Ethiopia: a retrospective cross-sectional study. BMC Health Services Research 17:1.
Crossref
Crossref
Macit Kalçık, Mahmut Yesin, Mustafa Ozan Gürsoy, Sabahattin Gündüz, Süleyman Karakoyun, Mehmet Ali Astarcıoğlu, Emrah Bayam, Sinan Cerşit & Mehmet Özkan. (2016) Comparison of the INR Values Measured by CoaguChek XS Coagulometer and Conventional Laboratory Methods in Patients on VKA Therapy. Clinical and Applied Thrombosis/Hemostasis 23:2, pages 187-194.
Crossref
Crossref
C Sekaggya, D Nalwanga, A Von Braun, R Nakijoba, A Kambugu, J Fehr, M Lamorde & B Castelnuovo. (2016) Challenges in achieving a target international normalized ratio for deep vein thrombosis among HIV-infected patients with tuberculosis: a case series. BMC Hematology 16:1.
Crossref
Crossref
Gregory Y.H. Lip, Stephen A. Mitchell, Xianchen Liu, Larry Z. Liu, Hemant Phatak, Sumesh Kachroo & Sarah Batson. (2016) Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups. International Journal of Cardiology 204, pages 88-94.
Crossref
Crossref
Duncan McNab, John McKay & Paul Bowie. (2015) A before and after study of warfarin monitoring in a single region as part of the Scottish patient safety programme in primary care. Scottish Medical Journal 60:4, pages 196-201.
Crossref
Crossref
Rafael Alonso Roca, Carmen Arlene Figueroa Guerrero, Victoria Mainar de Paz, M. Paz Arribas García, Luis Sánchez Perruca, Ricardo Rodríguez Barrientos, Mariano Casado López & Ana M. Pedraza Flechas. (2015) Grado de control del tratamiento anticoagulante oral en los centros de Atención Primaria de la Comunidad de Madrid: estudio CHRONOS-TAO. Medicina Clínica 145:5, pages 192-197.
Crossref
Crossref
Rafael Alonso Roca, Carmen Arlene Figueroa Guerrero, Victoria Mainar de Paz, M. Paz Arribas García, Luis Sánchez Perruca, Ricardo Rodríguez Barrientos, Mariano Casado López & Ana M. Pedraza Flechas. (2015) Quality control of oral anticoagulant therapy in Primary Care in Madrid City, Spain: CHRONOS-TAO study. Medicina Clínica (English Edition) 145:5, pages 192-197.
Crossref
Crossref
A.K. Samadoulougou, D.T. Naibe, D.G. Mandi, E. Kabore, G.R.C. Millogo, N.V. Yameogo, J.K. Kologo, A.T. Tall, B.J.Y. Toguyeni & P. Zabsonre. (2015) Évaluation du niveau de connaissance des patients sur la gestion du traitement par les antivitamines K dans le service de cardiologie de Ouagadougou. Annales de Cardiologie et d'Angéiologie 64:4, pages 263-267.
Crossref
Crossref
Ana Filipa Macedo, James Bell, Ciaran McCarron, Rachel Conroy, James Richardson, Anna Scowcroft, Tom Sunderland & Naj Rotheram. (2015) Determinants of oral anticoagulation control in new warfarin patients: analysis using data from Clinical Practice Research Datalink. Thrombosis Research 136:2, pages 250-260.
Crossref
Crossref
Agnes Rouaud, Olivier Hanon, Anne-Sophie Boureau, Guillaume Gilles Chapelet & Laure de Decker. (2015) Comorbidities against Quality Control of VKA Therapy in Non-Valvular Atrial Fibrillation: A French National Cross-Sectional Study. PLOS ONE 10:3, pages e0119043.
Crossref
Crossref
Fran?ois-Emery Cott?Hicham Benhaddi, Isabelle Duprat-Lomon, Adam Doble, Nick Marchant, Alexia Letierce & Michael Huguet. (2014) Vitamin K Antagonist Treatment in Patients With Atrial Fibrillation and Time in Therapeutic Range in Four European Countries. Clinical Therapeutics 36:9, pages 1160-1168.
Crossref
Crossref
Yogarabindranath Swarna Nantha. (2014) Anticoagulation Management of Atrial Fibrillation. Health Services Research and Managerial Epidemiology 1, pages 233339281455252.
Crossref
Crossref
MSH Lim, L Anchah, WN Tiong, SS Hwang, TK Ong, KH Sim & AYY Fong. (2014) Thrombin and FXa plasma concentration levels in patients with atrial fibrillation on long term warfarin therapy. ASEAN Heart Journal 22:1.
Crossref
Crossref
Peter Br?nnum Nielsen, S?ren Lundbye-Christensen, Lars Hvilsted Rasmussen & Torben Bjerregaard Larsen. (2014) Improvement of anticoagulant treatment using a dynamic decision support algorithm. Thrombosis Research 133:3, pages 375-379.
Crossref
Crossref
Sebastian Ewen, Volker Rettig-Ewen, Felix Mahfoud, Michael Böhm & Ulrich Laufs. (2013) Drug adherence in patients taking oral anticoagulation therapy. Clinical Research in Cardiology 103:3, pages 173-182.
Crossref
Crossref
Kálmán Havasi. (2014) Efficacy and safety of apixaban compared with warfarin regarding time within the therapeutic range. Orvosi Hetilap 155:5, pages 177-181.
Crossref
Crossref
Matthieu Plichart, Gilles Berrut, Nathalie Maubourguet, Claude Jeandel, Jean-Paul Emeriau, Jo?l Ankri, H?l?ne Bouvier, Genevi?ve Ruault & Olivier Hanon. (2013) Use of Vitamin K Antagonist Therapy in Geriatrics: A French National Survey from the French Society of Geriatrics and Gerontology (SFGG). Drugs & Aging 30:12, pages 1019-1028.
Crossref
Crossref
Laura G. Qualls, Melissa A. Greiner, Zubin J. Eapen, Gregg C. Fonarow, Roger M. Mills, Winslow Klaskala, Adrian F. Hernandez & Lesley H. Curtis. (2013) Postdischarge International Normalized Ratio Testing and Long-term Clinical Outcomes of Patients With Heart Failure Receiving Warfarin: Findings From the ADHERE Registry Linked to Medicare Claims. Clinical Cardiology 36:12, pages 757-765.
Crossref
Crossref
Kelechi C. Ogbonna & Sean M. Jeffery. (2013) Risk versus Benefit of Non-Vitamin K Dependent Anticoagulants Compared to Warfarin for the Management of Atrial Fibrillation in the Elderly. Drugs & Aging 30:7, pages 513-525.
Crossref
Crossref
Jack Ansell. (2013) Point-of-care patient self-monitoring of oral vitamin K antagonist therapy. Journal of Thrombosis and Thrombolysis 35:3, pages 339-341.
Crossref
Crossref
Edith A. Nutescu, Adriana Bautista, Weihua Gao, William L. Galanter, Glen T. Schumock, Samir H. Mody, Brahim K. Bookhart & Bruce L. Lambert. (2013) Warfarin anticoagulation after total hip or total knee replacement: Clinical and resource-utilization outcomes in a university-based antithrombosis clinic. American Journal of Health-System Pharmacy 70:5, pages 423-430.
Crossref
Crossref
Michela Basileo, Carlo Micheluzzi, Marina Minozzi, Luigi Lazzaroni & Alfonso Iorio. (2011) Clinical validation of a new algorithm for computerized dosing of vitamin K antagonist therapy: a retrospective simulation study. Internal and Emergency Medicine 8:1, pages 55-63.
Crossref
Crossref
Leanne Stafford, Ella C van Tienen, Luke R E Bereznicki & Gregory M Peterson. (2012) The benefits of pharmacist-delivered warfarin education in the home. International Journal of Pharmacy Practice 20:6, pages 384-389.
Crossref
Crossref
Maqual R. GrahamKristin FishR. Spencer Schaefer, Rick Galyean & Karen L. Hardinger. (2012) Evaluation of a Pharmacist-Managed Anticoagulation Clinic. Hospital Pharmacy 47:11, pages 848-854.
Crossref
Crossref
Gustavo Lamego de Barros Costa, Rosana Morais Lamego, Enrico A. Colosimo, Reginaldo Aparecido Valacio & Maria da Consolação Vieira Moreira. (2012) Identifying Potential Predictors of High-Quality Oral Anticoagulation Assessed by Time in Therapeutic International Normalized Ratio Range: A Prospective, Long-Term, Single-Center, Observational Study. Clinical Therapeutics 34:7, pages 1511-1520.
Crossref
Crossref
Mary E Bauman, Gordon Mack, Aisha K Bruce, Michelle L Bauman, Kyle Nolan & M Patricia Massicotte. (2012) Natural Health Product Utilization in Warfarinized Children; Prevalence and Knowledge. Journal of Pharmacy Technology 28:3, pages 100-105.
Crossref
Crossref
David G. Bundy, Jill A. Marsteller, Albert W. Wu, Lilly D. Engineer, Sean M. Berenholtz, A. Harrison Caughey, David Silver, Jing Tian, Richard E. Thompson, Marlene R. Miller & Christoph U. Lehmann. (2012) Electronic Health Record–Based Monitoring of Primary Care Patients at Risk of Medication-Related Toxicity. The Joint Commission Journal on Quality and Patient Safety 38:5, pages 216-AP2.
Crossref
Crossref
Hugo ten Cate. (2017) Monitoring new oral anticoagulants, managing thrombosis, or both?. Thrombosis and Haemostasis 107:05, pages 803-805.
Crossref
Crossref
Leanne Stafford, Gregory M Peterson, Luke RE Bereznicki & Shane L Jackson. (2011) A role for pharmacists in community-based post-discharge warfarin management: protocol for the 'the role of community pharmacy in post hospital management of patients initiated on warfarin' study. BMC Health Services Research 11:1.
Crossref
Crossref
Stephanie Young, Lisa Bishop, Laurie Twells, Carla Dillon, John Hawboldt & Patrick O'Shea. (2011) Comparison of pharmacist managed anticoagulation with usual medical care in a family medicine clinic. BMC Family Practice 12:1.
Crossref
Crossref
Stavros Apostolakis, Gregory YH Lip, Deirdre A Lane & Eduard Shantsila. (2011) The Quest for New Anticoagulants: From Clinical Development to Clinical Practice. Cardiovascular Therapeutics 29:6, pages e12-e22.
Crossref
Crossref
Gail B. Hefter & Janice Stack. (2011) Development of a dosing algorithm in a nurse-managed outpatient anticoagulation clinic. Journal of the American Academy of Nurse Practitioners 23:10, pages 546-551.
Crossref
Crossref
Brendan Cornec, Nathalie Nabbe & Emmanuel Oger. (2011) Knowledge and Wishes of Patients as Regards Vitamin K Antagonists: a Cross-sectional Survey inWestern Brittany, France. Therapies 66:4, pages 363-368.
Crossref
Crossref
Daniel M. Witt. (2011) Quality measures and benchmarking for warfarin therapy. Journal of Thrombosis and Thrombolysis 31:3, pages 242-248.
Crossref
Crossref
Leanne Stafford, Gregory M Peterson, Luke RE Bereznicki, Shane L Jackson, Ella C van Tienen, Manya T Angley, Beata V Bajorek, Andrew J McLachlan, Judy R Mullan, Gary MH Misan & Luigi Gaetani. (2011) Clinical Outcomes of a Collaborative, Home-Based Postdischarge Warfarin Management Service. Annals of Pharmacotherapy 45:3, pages 325-334.
Crossref
Crossref
Donald Roberts & Petra Flanagan. (2011) Case Report. Home Healthcare Nurse 29:2, pages 92-97.
Crossref
Crossref
Sorin J. Brener. (2010) The Reply. The American Journal of Medicine 123:11, pages e15.
Crossref
Crossref
Denise Bockwoldt. (2010) Antithrombosis Management in Community-Dwelling Elderly: Improving Safety. Geriatric Nursing 31:1, pages 28-36.
Crossref
Crossref